Trial Profile
Fasted state bioavailability of two delayed release formulations of divalproex sodium in healthy Iranian volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Sep 2011
Price :
$35
*
At a glance
- Drugs Valproate semisodium (Primary)
- Indications Bipolar disorders; Epilepsy; Migraine
- Focus Pharmacokinetics
- 28 Sep 2011 New trial record